Evaluation of allogeneic haematopoietic stem cell transplantation and pre- and post-transplant therapy in high-risk patients with chronic myeloid leukaemia

被引：0
|
作者：
Oyekunle, A. [1 ]
Klyuchnikov, E. [1 ]
Kroeger, N. [1 ]
Zabelina, T. [1 ]
Ayuk, F. [1 ]
Wolschke, C. [1 ]
Bernhardt, F. [1 ]
Mueller, I. [1 ]
Zander, A. [1 ]
Bacher, U. [1 ]
机构：
[1] Clin Stem Cell Transplantat, Hamburg, Germany
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S363 / S363
页数：1
相关论文
共 50 条
  • [1] Post-transplant immune reconstitution after allogeneic stem cell transplantation in paediatric patients with high-risk leukaemia
    Rigatou, E.
    Gumy-Pause, F.
    Mattiello, V.
    Chalandon, Y.
    Ansari, M.
    Ozsahin, H.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S149 - S150
  • [2] Outcome of allogeneic haematopoietic stem cell transplantation in patients with atypical chronic myeloid leukaemia
    Koldehoff, M.
    Elmaagacli, A. H.
    Ditschkowski, M.
    Beelen, D. W.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S428 - S428
  • [3] Pre- and Post-Transplant Nutritional Assessment in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Park, Mi Young
    Park, Jeong Yun
    ASIAN ONCOLOGY NURSING, 2012, 12 (01) : 110 - 116
  • [4] Maintenance therapy with decitabine after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia and high-risk myelodysplastic syndrome
    Pusic, I.
    Choi, J.
    Bernabe, N.
    Abboud, C.
    Westervelt, P.
    Vij, R.
    Cashen, A.
    Uy, G.
    Stockerl-Goldstein, K.
    Holt, M.
    DiPersio, J.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S340 - S341
  • [5] PRE- AND POST-TRANSPLANT FACTORS PREDICT LONG TERM SURVIVAL AFTER REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION IN ACUTE MYELOID LEUKAEMIA
    Craddock, C.
    Nagra, S.
    Duncan, N.
    Mackinnon, S.
    Russell, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 339 - 339
  • [6] TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation
    Middeke, Jan M.
    Herold, Sylvia
    Ruecker-Braun, Elke
    Berdel, Wolfgang E.
    Stelljes, Matthias
    Kaufmann, Martin
    Schaefer-Eckart, Kerstin
    Baldus, Claudia D.
    Stuhlmann, Reingard
    Ho, Anthony D.
    Einsele, Hermann
    Roesler, Wolf
    Serve, Hubert
    Haenel, Mathias
    Sohlbach, Kristina
    Klesse, Christian
    Mohr, Brigitte
    Heidenreich, Falk
    Stoelzel, Friedrich
    Roellig, Christoph
    Platzbecker, Uwe
    Ehninger, Gerhard
    Bornhaeuser, Martin
    Thiede, Christian
    Schetelig, Johannes
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 172 (06) : 914 - 922
  • [7] Donor type is not predictive for survival after allogeneic haematopoietic stem cell transplantation in high-risk acute myeloid leukaemia
    Schetelig, J.
    Beelen, D.
    Stadler, M.
    Baurmann, H.
    Martin, H.
    Bellos, F.
    Birninger, N.
    Ganser, A.
    Schwerdfeger, R.
    Bug, G.
    Hegenbart, U.
    Bornhaeuser, M.
    Ehninger, G.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S40 - S40
  • [8] Allogeneic haematopoietic stem cell transplantation for patients with chronic lymphocytic leukaemia
    Zaucha, J. M.
    Bieniaszewska, M.
    Piekarska, A.
    Prejzner, W.
    Knopinska-Posluszny, W.
    Hellmann, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S316 - S316
  • [9] Update on post transplant immune reconstitution after allogeneic stem cell transplantation in paediatric high-risk leukaemia patients
    Rigatou, E.
    Pause, F. Gummy
    Mattiello, V.
    Chalandon, Y.
    Ansari, M.
    Ozsahin, H.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S366 - S367
  • [10] Allogeneic myeloablative haematopoietic stem cell transplantation for chronic myeloid leukaemia in the imatinib era
    Pavlu, J.
    Auner, H.
    Szydlo, R.
    Olavarria, E.
    Giles, C.
    Klammer, M.
    Kew, A.
    Milojkovic, D.
    Gabriel, I.
    Rezvani, K.
    Dazzi, F.
    Marin, D.
    Goldman, J.
    Apperley, J.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S49 - S49
12345